Next Article in Journal
Practical Recommendations for the Manipulation of Kinase Inhibitor Formulations to Age-Appropriate Dosage Forms
Next Article in Special Issue
Safety of Rifampicin at High Dose for Difficult-to-Treat Tuberculosis: Protocol for RIAlta Phase 2b/c Trial
Previous Article in Journal
Recent Advances in the Biomedical Applications of Functionalized Nanogels
Previous Article in Special Issue
Management of Anti-Seizure Medications during Pregnancy: Advancements in The Past Decade
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(12), 2833; https://doi.org/10.3390/pharmaceutics14122833
Action Date Notes Link
article pdf uploaded. 16 December 2022 17:07 CET Version of Record https://www.mdpi.com/1999-4923/14/12/2833/pdf-vor
article supplementary file uploaded. 16 December 2022 17:07 CET - https://www.mdpi.com/1999-4923/14/12/2833#supplementary
article xml file uploaded 20 December 2022 10:13 CET Original file -
article xml uploaded. 20 December 2022 10:13 CET Update https://www.mdpi.com/1999-4923/14/12/2833/xml
article pdf uploaded. 20 December 2022 10:13 CET Updated version of record https://www.mdpi.com/1999-4923/14/12/2833/pdf
article html file updated 20 December 2022 10:15 CET Original file -
article html file updated 1 March 2023 04:42 CET Update -
article html file updated 4 March 2023 22:25 CET Update https://www.mdpi.com/1999-4923/14/12/2833/html
Back to TopTop